M. Arias

5.7k total citations
163 papers, 2.2k citations indexed

About

M. Arias is a scholar working on Transplantation, Surgery and Epidemiology. According to data from OpenAlex, M. Arias has authored 163 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Transplantation, 46 papers in Surgery and 43 papers in Epidemiology. Recurrent topics in M. Arias's work include Renal Transplantation Outcomes and Treatments (57 papers), Liver Disease Diagnosis and Treatment (27 papers) and Organ Transplantation Techniques and Outcomes (19 papers). M. Arias is often cited by papers focused on Renal Transplantation Outcomes and Treatments (57 papers), Liver Disease Diagnosis and Treatment (27 papers) and Organ Transplantation Techniques and Outcomes (19 papers). M. Arias collaborates with scholars based in Spain, United States and Germany. M. Arias's co-authors include Javier Crespo, Juan Carlos Ruiz, Gema Fernández‐Fresnedo, Emilio Rodrigo, Celestino Piñera, Paula Iruzubieta, C. Gómez-Alamillo, Marcos López‐Hoyos, Ángel L.M. de Francisco and R. Palomar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

M. Arias

149 papers receiving 2.1k citations

Peers

Countries citing papers authored by M. Arias

Since Specialization

Citations

This map shows the geographic impact of M. Arias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arias more than expected).

Fields of papers citing papers by M. Arias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arias. The network helps show where M. Arias may publish in the future.

Co-authorship network of co-authors of M. Arias

This figure shows the co-authorship network connecting the top 25 collaborators of M. Arias. A scholar is included among the top collaborators of M. Arias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Arias. M. Arias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk 2023 ·Immunity & Ageing ·Rubén Martín‐Escolano, (unknown), Javier Crespo, Pablo Ryan, Luís Miguel Real, (unknown), Joaquín Cabezas, Juan Macı́as, M. Arias, Guillermo Cuevas, Ana Virseda‐Berdices, Verónica Briz, Salvador Resino, María Ángeles Jiménez‐Sousa, Amanda Fernández‐Rodríguez	4
2	Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review 2023 ·International Journal of Molecular Sciences ·(unknown), Álvaro Santos‐Laso, (unknown), Joaquín Cabezas, Paula Iruzubieta, M. Arias, (unknown), (unknown), (unknown), Emilio Fábrega, Javier Crespo	15
3	Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Álvaro Santos‐Laso, M. Arias, Paula Iruzubieta, Javier Crespo	9
4	High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease 2023 ·Liver International ·(unknown), Ángela Puente, Antonio Cuadrado, Paula Iruzubieta, M. Arias, Carlos Redondo, (unknown), Emilio Fábrega, Javier Crespo, José Ignacio Fortea	13
5	Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets 2021 ·Biomedicines ·Álvaro Santos‐Laso, (unknown), (unknown), (unknown), Paula Iruzubieta, M. Arias, Marcos López‐Hoyos, Javier Crespo	18
6	Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells 2021 ·Viruses ·M. Arias, Joaquín Cabezas, Susana Llerena, Paula Iruzubieta, David San Segundo, David Merino, Antonio Cuadrado, José P. Vaqué, Marcos López‐Hoyos, Javier Crespo	2
7	Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy 2019 ·Journal of Clinical Medicine ·Ángela Puente, José Ignacio Fortea, (unknown), (unknown), (unknown), Joaquín Cabezas, M. Arias, Susana Llerena, Paula Iruzubieta, Emilio Fábrega, Javier Crespo	6
8	MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection 2019 ·Journal of Clinical Medicine ·Oscar Brochado‐Kith, (unknown), Luís Miguel Real, Javier Crespo, Pablo Ryan, Juan Macı́as, Joaquín Cabezas, Jesús Troya, Juan A. Pineda, M. Arias, (unknown), María Ángeles Jiménez‐Sousa, Luz María Medrano, (unknown), Sara Monzón, Salvador Resino, Amanda Fernández‐Rodríguez	9
9	LOXL2—A New Target in Antifibrogenic Therapy? 2019 ·International Journal of Molecular Sciences ·Ángela Puente, José Ignacio Fortea, Joaquín Cabezas, M. Arias, Paula Iruzubieta, Susana Llerena, Patrícia Huelin, Emilio Fábrega, Javier Crespo	57
10	An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity 2019 ·Revista Española de Enfermedades Digestivas ·Esther Nistal, Luis E. Sáenz de Miera, María D. Ballesteros‐Pomar, Sonia Sánchez‐Campos, María Victoria García‐Mediavilla, (unknown), P. Linares, J.L. Olcoz, M. Arias, (unknown), Javier Crespo, Javier González‐Gallego, Francisco Jorquera	47
11	Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It 2019 ·Cells ·Ángela Puente, José Ignacio Fortea, (unknown), Patrícia Huelin, (unknown), (unknown), Joaquín Cabezas, M. Arias, Paula Iruzubieta, Antonio Cuadrado, Susana Llerena, Carlos López, Emilio Fábrega, Javier Crespo	20
12	Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey 2018 ·Digestive and Liver Disease ·José Ignacio Fortea, Ángela Puente, (unknown), Antonio Cuadrado, M. Arias, Joaquín Cabezas, Susana Llerena, Paula Iruzubieta, Carlos Rodríguez de Lope, Patrícia Huelin, Fernando Casafont, Emilio Fábrega, Javier Crespo	8
13	Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants 2017 ·PLoS ONE ·Carles Bautista-Rodríguez, Cristian Launes, Iolanda Jordán, (unknown), M. Arias, Francisco Lozano, Juan José García‐García, Carmen Muñoz‐Almagro	7
14	Intraepithelial lymphocytes subsets in different forms of celiac disease 2016 ·PubMed ·María Sánchez‐Castañón, Beatriz Castro, (unknown), (unknown), M. Arias, Paula Iruzubieta, Javier Crespo, Marcos López‐Hoyos	16
15	Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease 2016 ·International Journal of Molecular Sciences ·M. Arias, Paula Iruzubieta, Ángela Puente, David Ramos‐Barbón, (unknown), Á. Estébanez, Susana Llerena, Carmen Alonso-Martín, David San Segundo, (unknown), (unknown), Emilio Fábrega, Marcos López‐Hoyos, Javier Crespo	28
16	[Leukopenia in kidney transplantation resulting from the interaction between mycophenolate mofetil and valganciclovir]. 2007 ·PubMed ·María Jesús Izquierdo, Emilio Rodrigo, (unknown), M. Arias	2
17	Clinical Significance of Antiphospholipid Antibodies on Allograft and Patient Outcome After Kidney Transplantation 2005 ·Transplantation Proceedings ·Gema Fernández‐Fresnedo, Marcos López‐Hoyos, David San Segundo, Javier Crespo, Juan Carlos Ruiz, Ángel L.M. de Francisco, M. Arias	8
18	Desarrollo y aplicación de una prueba de RCP para detectar la infección subclínica por Mycobacterium leprae 2002 ·Revista Panamericana de Salud Pública ·(unknown), M. Arias, (unknown), Clara Inés León	8
19	The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation. 1991 ·PubMed ·J.G Cotorruelo, (unknown), (unknown), J.A. Amado, (unknown), E. De Bonis, J.A Zubimendi, Juan Carlos Ruiz, S. Castro, M. Arias	5
20	Poststreptococcal glomerulonephritis. 1979 ·BMJ ·Miguel García‐Fuentes, M. Arias	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact